AK

Aneesh Kumar Kochikalayil Anilkumar

Active Director Director DIN 11145824
DIN 11145824 First appointment Jun 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Aneesh Kumar Kochikalayil Anilkumar

Data last updated:

Aneesh Kumar Kochikalayil Anilkumar is a Director at Mistel Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11145824
Primary Designation Director
Industry Pharma
First Appointment 09 Jun 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Jun 20252025Active

Board colleagues of Aneesh Kumar Kochikalayil Anilkumar

NameDINCompanyDesignation
George Jayasingh11145823Mistel Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mistel Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Aneesh Kumar Kochikalayil Anilkumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Aneesh Kumar Kochikalayil Anilkumar

Aneesh Kumar Kochikalayil Anilkumar currently holds 1 directorship: Mistel Pharmaceuticals Private Limited (Director, since 09 Jun 2025).

Aneesh Kumar Kochikalayil Anilkumar was first appointed on 09 Jun 2025 as Director at Mistel Pharmaceuticals Private Limited.

The current boards of Aneesh Kumar Kochikalayil Anilkumar's companies include George Jayasingh (Mistel Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available